Pulmonary Embolism (PE) is the third most common cause of cardiovascular mortality in the
United States, with 60,000-100,000 deaths per year following myocardial infarction and …

Introduction Pulmonary embolism (PE) represents one of the leading causes of death
worldwide and mainly treated with medical management, although the utility of more …

Currently, guidelines and recommendations are important tools to help physicians related
with acute pulmonary embolism patient care to weigh the benefits and risks of …

Background Pulmonary embolism (PE) with cor pulmonale causes considerable mortality
and morbidity. Randomized trials have failed to show a mortality difference between …

Background We aimed to review the efficacy and safety of recanalisation procedures for the
treatment of PE. Methods We searched PubMed, the Cochrane Library, EMBASE, EBSCO …

Background The optimal therapy for submassive pulmonary embolism remains in question.
The following meta-analysis compiles the current evidence comparing Catheter-Directed …

Background The impact of major changes in the treatment practice of pulmonary embolism
(PE), such as limited indications for systemic thrombolysis and the introduction of direct oral …

Purpose The aim of this systematic review was to evaluate the efficacy and safety of
thrombolytic treatment in patients with submassive pulmonary embolism (PE). Methods An …

Pulmonary embolism (PE) treatment depends on disease severity and risk of complications.
Physician and institutional expertise may influence the use of reperfusion therapy (RT) such …

Background Improved prediction of the risk of major bleeding in patients with acute
pulmonary embolism (PE) receiving systemic thrombolysis is crucial to guide the choice of …